Novartis was announced as an official partner of this year’s Eurovision competition last fall, after the song entry from ...

Experienced leader in radiopharmaceutical drug development, regulatory, and clinical strategies will advance ITM’s broad pipeline and clinical ...

Swiss Drugmakers Novartis and Roche Ditch Some Diversity Programmes on US ... Roche said its Chief Diversity Offices in the U.S. and at its Basel headquarters "will focus on inclusion and belonging, ...

Karen Hale, who joined Novartis in 2021 as chief legal officer, will take on the new chief legal and compliance officer role.

Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novartis AG (NOVN – Research Report) today and set a price target of ...

ZURICH, March 19 (Reuters) - Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending ... in the U.S. and at its Basel headquarters "will focus ...

ZURICH, March 19 (Reuters) - Swiss drugmaker Novartis (NOVN.S), opens new tab is ending its use of diverse panels for all of its hiring in the United States, the company told Reuters on Wednesday, ...

ZURICH (Reuters) -Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse ... Roche said its Chief Diversity Offices in the U.S. and ...

OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company dedicated to advancing healthcare outcomes and improving the ...

Speaking to journalists at Novartis headquarters in Basel, Switzerland, last week, Hughes said its recent in-licensing of a second NASH pipeline drug from Conatus would help put it in pole position.

Joint research activities will be carried out at Novartis’ sites in Basel, Switzerland, and Dublin, Ireland, as well as at the Microsoft Research Lab in Cambridge, UK. Takeda's Adcetris has ...